Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,785,977 | 2,445,750 | 2,333,230 | 2,094,462 | 1,882,033 |
| Depreciation Amortization | 827,431 | 828,000 | 784,240 | 727,754 | 686,085 |
| Accounts receivable | -260,790 | N/A | N/A | N/A | N/A |
| Other Working Capital | -445,197 | -419,950 | 0 | -338,453 | -239,861 |
| Other Operating Activity | 192,197 | 83,720 | -384,570 | 145,004 | 53,805 |
| Operating Cash Flow | $3,099,618 | $2,937,520 | $2,732,900 | $2,628,767 | $2,382,062 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,035,873 | -987,090 | -990,610 | -1,007,296 | -949,028 |
| Net Acquisitions | 205,000 | -217,000 | -249,170 | -200,475 | -830,559 |
| Purchase Of Investment | -68,085 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 235,839 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 45,455 | 5,850 | -181,080 | 10,100 | -175,654 |
| Investing Cash Flow | $-617,664 | $-1,198,240 | $-1,420,860 | $-1,197,671 | $-1,955,241 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -672,769 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 135,570 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -464,856 | N/A | N/A | N/A | N/A |
| Dividend Paid | -1,145,894 | -1,003,290 | -891,660 | -809,554 | -728,147 |
| Other Financing Activity | 0 | -423,530 | -342,020 | -498,945 | 135,859 |
| Financing Cash Flow | $-2,147,949 | $-1,426,820 | $-1,233,680 | $-1,308,499 | $-592,288 |
| Exchange Rate Effect | -27,884 | -19,580 | -140 | -2,782 | -5,521 |
| Beginning Cash Position | 608,097 | 315,230 | 230,020 | 110,209 | 281,197 |
| End Cash Position | 914,218 | 608,090 | 308,230 | 230,024 | 110,209 |
| Net Cash Flow | $306,121 | $292,850 | $78,200 | $119,815 | $-170,988 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,099,618 | 2,937,520 | 2,732,900 | 2,628,767 | 2,382,062 |
| Capital Expenditure | -1,035,873 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 2,063,745 | 2,937,520 | 2,732,900 | 2,628,767 | 2,382,062 |